FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to field of pharmaceutics and medicine and deals with pharmaceutical composition with delayed release, which contains as active ingredient octreotide or its pharmaceutically acceptable salt and two different linear copolymers of polylactide and glycolide (LCPG), characterised by molar ratios lactide/glycolide 75:25 and different values of viscosity, for prolonged supportive treatment of patients with acromegaly and for treatment of severe forms of diarrhoea and hyperaemia, associated with malignant carcinoid tumours and tumours, cells of which produce vasoactive intestinal peptide.
EFFECT: group of inventions ensure stably high level and fast achievement of required level of impact of active substance.
10 cl, 5 ex, 3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION WITH DELAYED RELEASE, INCLUDING OCTREOTIDE AND TWO OR MORE POLYLACTIDE AND GLYCOLIDE COPOLYMERS | 2006 |
|
RU2464972C2 |
| PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) | 2009 |
|
RU2541104C2 |
| PHARMACEUTICAL COMPOSITIONS AND RESPECTIVE DELIVERY METHODS | 2009 |
|
RU2552324C2 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF DODECAPEPTIDE INGRAMON | 2022 |
|
RU2793124C1 |
| PHARMACEUTICAL COMPOSITION, CONTAINING OCTREOTIDE MICROPARTICLES | 2003 |
|
RU2404748C2 |
| NEW METHODS | 2014 |
|
RU2682658C1 |
| CORTICOSTEROIDS FOR JOINT PAIN TREATMENT | 2011 |
|
RU2642279C2 |
| SUSTAINED-RELEASE COMPOSITIONS AND METHOD OF THEIR PREPARING | 1998 |
|
RU2198678C2 |
| OCTREOTIDE DELIVERY FROM DRY DOSAGE FORMS | 2009 |
|
RU2518745C2 |
| OCTREOTIDE IMPLANT CONTAINING RELEASING SUBSTANCE | 2009 |
|
RU2521291C2 |
